The landscape of U.S. immigration law is constantly shifting; don’t let this uncertainty impact your business.
It is crucial for employers to stay informed about the ever-evolving landscape of U.S. immigration laws and policies. This webinar will provide a comprehensive overview of the latest developments in immigration law, discuss the Trump administration’s executive orders and their impact on immigration and your business, review critical compliance requirements, and share proactive strategies for employers.
In this session, you will learn:
- A detailed review of current immigration enforcement activity impacting employers
- Analysis of recent policy changes and potential future developments
- Why you may want to review your “public space vs. private space” policies
- Strategies for preparing for ICE audits and worksite enforcement actions
- What types of enforcement actions to expect
- Best practices for mitigating legal risks
Join us and gain practical insights to ensure your business remains compliant and your workforce secure.
For a PDF of the presentation, please click here.
Webinar Recording
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…